Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/141852
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRío Fernández, José Antonio del-
dc.contributor.authorFerrer, Isidro (Ferrer Abizanda)-
dc.contributor.authorGavín Marín, Rosalina-
dc.date.accessioned2019-10-08T17:04:24Z-
dc.date.available2019-12-01T06:10:16Z-
dc.date.issued2018-06-01-
dc.identifier.issn0301-0082-
dc.identifier.urihttp://hdl.handle.net/2445/141852-
dc.description.abstractSeveral studies have indicated that certain misfolded amyloids composed of tau, β-amyloid or α-synuclein can be transferred from cell to cell, suggesting the contribution of mechanisms reminiscent of those by which infective prions spread through the brain. This process of a 'prion-like' spreading between cells is also relevant as a novel putative therapeutic target that could block the spreading of proteinaceous aggregates throughout the brain which may underlie the progressive nature of neurodegenerative diseases. The relevance of β-amyloid oligomers and cellular prion protein (PrPC) binding has been a focus of interest in Alzheimer's disease (AD). At the molecular level, β-amyloid/PrPC interaction takes place in two differently charged clusters of PrPC. In addition to β-amyloid, participation of PrPC in α-synuclein binding and brain spreading also appears to be relevant in α-synucleopathies. This review summarizes current knowledge about PrPC as a putative receptor for amyloid proteins and the physiological consequences of these interactions.-
dc.format.extent16 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherElsevier Ltd-
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1016/j.pneurobio.2018.03.001-
dc.relation.ispartofProgress in Neurobiology, 2018, vol. 165-167, p. 87-102-
dc.relation.urihttps://doi.org/10.1016/j.pneurobio.2018.03.001-
dc.rightscc-by-nc-nd (c) Elsevier Ltd, 2018-
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es-
dc.sourceArticles publicats en revistes (Patologia i Terapèutica Experimental)-
dc.subject.classificationAmiloïdosi-
dc.subject.classificationPèptids-
dc.subject.classificationMetabolisme-
dc.subject.classificationAlfa-sinucleïna-
dc.subject.classificationProteïnes-
dc.subject.otherAmyloidosis-
dc.subject.otherPeptides-
dc.subject.otherMetabolism-
dc.subject.otherAlpha-synuclein-
dc.subject.otherProteins-
dc.titleRole of cellular prion protein in interneuronal amyloid transmission-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/acceptedVersion-
dc.identifier.idgrec679823-
dc.date.updated2019-10-08T17:04:24Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid29530723-
Appears in Collections:Articles publicats en revistes (Institut de Bioenginyeria de Catalunya (IBEC))
Articles publicats en revistes (Patologia i Terapèutica Experimental)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
679823.pdf1.57 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons